Cytokinetics, Incorporated
CYTK
$59.32
-$0.68-1.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -183.03M | -306.18M | -134.37M | -161.38M | -150.02M |
| Total Depreciation and Amortization | 2.86M | 2.68M | 2.29M | 2.30M | 2.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.36M | 173.46M | 54.96M | 32.66M | 40.35M |
| Change in Net Operating Assets | -1.85M | 22.53M | -51.11M | -5.20M | 41.71M |
| Cash from Operations | -142.65M | -107.51M | -128.24M | -131.62M | -65.57M |
| Capital Expenditure | -5.64M | -9.35M | -4.15M | -5.66M | -1.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -65.55M | -61.63M | 57.03M | 111.62M | 112.15M |
| Cash from Investing | -71.19M | -70.98M | 52.88M | 105.96M | 110.86M |
| Total Debt Issued | 0.00 | 729.46M | -- | -- | -- |
| Total Debt Repaid | -2.72M | -405.21M | -2.70M | -2.88M | -2.91M |
| Issuance of Common Stock | 14.65M | 6.94M | 6.75M | 7.65M | 6.48M |
| Repurchase of Common Stock | -1.22M | -720.00K | -514.00K | -13.00K | -1.18M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00M | 0.00 | 75.00M | -- | 0.00 |
| Cash from Financing | 110.71M | 330.47M | 78.53M | 4.75M | 2.38M |
| Foreign Exchange rate Adjustments | 191.00K | 46.00K | -682.00K | -270.00K | 292.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.95M | 152.03M | 2.50M | -21.18M | 47.97M |